Medison Pharma announces multi-regional agreement with argenx to commercialize Efgartigimod
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
The campaign aims to promote an integrated view by combining Ayurveda and Yoga to create harmony not just within the body, but also in our minds
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform
The new advanced regional processing lab will serve Nagpur city and the Vidarbha region
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
The Portal BioRRAP will cater to all those seeking regulatory approval for biological research
The European Commission granted CMA in December 2021 for use of Nuvaxovid in individuals aged 18 and over, and Novavax filed for expanded CMA for use in adolescents aged 12 through 17 in March 2022
Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals
Subscribe To Our Newsletter & Stay Updated